Regulatory agencies surveying hospitals have high expectations of pharmacy departments when it comes to monitoring the use, and potential diversion of, controlled substances. To meet those expectations, facilities should require internal audits to help identify clinicians with unusual dispensing patterns that might be indicative of diverting controlled substances. When unusual patterns are identified the challenging work begins—investigation, and in cases of proven diversion, confronting the diverter and reporting these events to the appropriate agencies.
To read the full article, please log in or register.
- Armstrong Medical Industries, Inc
- Avancen MOD Corporation
- CompX Security Products
- Cooper-Atkins Corporation
- em innovations
- H+H System, Inc
- Health Care Logistics
- Healthmark Industries Company, Inc
- Marathon Products, Inc
- Medi-Dose, Inc / EPS, Inc
- Medicus Health
- Tangent, Inc
- Total Pharmacy Supply, Inc
Implementing a Strategy for Drug Cost Management
P&Ps and Competency Assessments for PPE and Cleaning
USP-Compliant Outpatient Center Renovation Part II
Choosing a DSCSA Compliance Service
Pharmacy's Role in Increasing Vaccination Rates
- In The Loop!
- Digital Edition
- Special Announcements